The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Mar. 07, 2007
Applicants:

Norbert Sprenger, Savigny, CH;

Francois Morgan, Rennes, FR;

Rafael Berrocal, Saint-Legier, CH;

Marcel Braun, Konolfingen, CH;

Christine Cherbut, Pully, CH;

Peter Duncan, Epalinges, CH;

Inventors:

Norbert Sprenger, Savigny, CH;

Francois Morgan, Rennes, FR;

Rafael Berrocal, Saint-Legier, CH;

Marcel Braun, Konolfingen, CH;

Christine Cherbut, Pully, CH;

Peter Duncan, Epalinges, CH;

Assignee:

Nestec S.A., Vevey, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A23L 1/308 (2006.01); A23L 1/0528 (2006.01); A23C 9/123 (2006.01); A01N 63/02 (2006.01); A23C 9/142 (2006.01); A23L 1/29 (2006.01); A23L 1/30 (2006.01); A61K 47/26 (2006.01); A01N 63/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A23C 9/1425 (2013.01); A23L 1/296 (2013.01); A23L 1/30 (2013.01); A23L 1/3014 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/73 (2013.01); A23Y 2300/55 (2013.01); A61K 35/745 (2013.01); A61K 47/26 (2013.01);
Abstract

This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising Ga1NAcα1,3Ga1β1,4G1c and Ga1β1,6Ga1NAcα1,3Ga1β1,4G1c, 20-95 wt % of at least one neutral oligosaccharide selected from the group comprising Ga1β1,6Ga1, Ga1β1,6Ga1β1,4G1c Ga1β1,6Ga1β1,6G1c, Ga1β1,3Ga1β1,3G1c, Ga1β1,3Ga1β1,4G1c, Ga1β 1,6Ga1β 1,6Ga1β 1,4GIc, Ga1β 1,6Ga1β 1,3Ga1β 1,4GIc Ga1β 1,3Ga1β 1,6Ga1β 1,4GIc and Ga1β1,3Ga1β1,3Ga1β1,4G1c and 2-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAcα2,3Ga1β1,4G1c and NeuAcα2,6Ga1β1,4G1c. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.


Find Patent Forward Citations

Loading…